NOX4 inhibitors (University of California Los Angeles)

N/A

Report date: 2025/03/20 09:16:53
NME

Base Information

Drug NameNOX4 inhibitors (University of California Los Angeles)
Drug Alias NameNADPH Oxidase 4 inhibitors (University of California Los Angeles)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase inhibitorsNADPH oxidase 4 inhibitors
TargetsNADPH oxidase 4Superoxide dismutase
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CaliforniaUniversity Of California, Los Angeles
Inactive CompaniesN/A
Active IndicationsAtrial Fibrillation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A